| Original language | English |
|---|---|
| Journal | Unknown Journal |
| Publication status | Published - 2000 |
Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulation hormone is effective, safe and convenient: results of a controlled, randomized, multicentr e trial.
G. Borm, Bernadette Mannaerts
Research output: Contribution to journal › Article › peer-review